Depressive Disorder News and Research

RSS

Mental disorders highly prevalent during coronavirus pandemics

Researchers in the United States have conducted an analysis showing the high prevalence of mental disorders across populations impacted by coronavirus pandemics.

24 Dec 2020

Targeted brain stimulation dulls social pain

A new study demonstrates that targeted brain stimulation is effective at dulling social pain.

18 Dec 2020

Newly discovered brain pattern could improve the diagnosis of mental health disorders

A pattern in how the brain breaks down tryptophan, a common amino acid consumed through food, was discovered by researchers at The University of Texas Health Science Center at Houston (UTHealth).

18 Dec 2020

4E-BP proteins are key to unlock the antidepressant effect of ketamine in the brain

A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The discovery could lead to better and safer treatments for certain patients suffering from major depression.

17 Dec 2020

Landmark heart study reveals new insights about risk factors for depression

Recently published UT Southwestern research reveals new insights about risk factors for depression based on data from a landmark longitudinal study focused on heart disease.

14 Dec 2020

New framework proposed for eliminating defects in behavioral health treatment

A new paper from the Department of Psychiatry and the Population Health program at University Hospitals Cleveland Medical Center, proposes a framework for eliminating defects in behavioral health treatment.

24 Nov 2020

New legal push aims to speed magic mushrooms to dying patients

Back in March, just as anxiety over COVID-19 began spreading across the U.S., Erinn Baldeschwiler of La Conner, Washington, found herself facing her own private dread.

24 Nov 2020

Study uses non-invasive technique to help veterans with depression, concussion

Studies using repetitive transcranial magnetic stimulation (rTMS), a non-invasive technique, to help veterans and active-duty service members living with depression, post-traumatic stress disorder (PTSD), and other lasting consequences of concussion have shown promise.

6 Nov 2020

Psilocybin may be effective in patients suffering from major depression

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.

4 Nov 2020

Study examines mental health indicators during the 2016 general election

Whether a Trump triumph or a Biden victory, millions of Americans may expect a decline in their mental health if they live in states that favor the losing candidate.

3 Nov 2020

Brain imaging biomarker may help predict treatment response in patients with psychiatric disorders, study reveals

Cohen Veterans Bioscience, a non-profit research biotech advancing brain health solutions, today announces findings from a study which generates new evidence in support of a critical brain imaging biomarker, that may help guide people who suffer from post-traumatic stress disorder or major depressive disorder towards the most effective treatment.

21 Oct 2020

Mental health of undocumented college students worst hit by COVID-19 pandemic

A new study by researchers at Delaware State University and published on the preprint server medRxiv in September 2020 reports that the impact on mental health is disproportionately felt among undocumented immigrants studying in US colleges.

5 Oct 2020

Weighted blanket intervention reduces insomnia severity

Weighted blankets are a safe and effective intervention in the treatment of insomnia, according to Swedish researchers who found that insomnia patients with psychiatric disorders experienced reduced insomnia severity, improved sleep and less daytime sleepiness when sleeping with a weighted chain blanket.

23 Sep 2020

Study highlights the need for new strategies to treat patients with treatment-resistant depression

Clinical trials happen in a highly controlled setting and while they are extremely useful in gathering robust information about drugs and how they work, there are many more variables that might affect how a drug works in a real-life setting outside of clinical trials e.g. different patient populations and environments.

21 Sep 2020

Scientists investigate how psychedelic drugs interact with brain cells at the molecular level

Psychedelic drugs such as LSD, psilocybin, and mescaline cause severe and often long-lasting hallucinations, but they show great potential in treating serious psychiatric conditions, such as major depressive disorder.

18 Sep 2020

First clinical trial launched to test psilocybin therapy for depression in cancer patients

The first clinical trial to test the safety and feasibility of psilocybin therapy with simultaneous administration and one-on-one patient support to treat depression in cancer patients was launched today by Maryland Oncology Hematology at the Aquilino Cancer Center at Adventist HealthCare Shady Grove Medical Center.

16 Sep 2020

Non-invasive test of brain function could predict treatment response in depressed teen girls

The risk of developing major depressive disorder (MDD) surges during adolescence-particularly for girls. Cognitive behavioral therapy (CBT) can be an effective treatment, but only about half of girls diagnosed with depression show significant improvement.